Atlas Trials

Predictive Role of MIDAS Reduction at 3 Months for Erenumab Treatment

Clinical trial NCT05442008 · COMPLETED

Trial details

NCT number
NCT05442008
Sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
Status
COMPLETED
Study type
OBSERVATIONAL
Migraine
Start date
2018-12-01
Primary completion
2020-01-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.